Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View
出版年份 2013 全文链接
标题
Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 38, Pages 27059-27067
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2013-08-14
DOI
10.1074/jbc.m113.491530
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Letter: are infliximab and adalimumab similar for Crohn's disease in clinical practice?
- (2013) A. Tursi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Structural Basis for Treating Tumor Necrosis Factor α (TNFα)-associated Diseases with the Therapeutic Antibody Infliximab
- (2013) Shuaiyi Liang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis
- (2013) Noam Y. Kirson et al. JOURNAL OF MEDICAL ECONOMICS
- Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study
- (2012) F. Zorzi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infliximab for Crohn’s Disease: The First 500 Patients Followed Up Through 2009
- (2012) Jennifer L. Seminerio et al. DIGESTIVE DISEASES AND SCIENCES
- Engineering Fully Human Monoclonal Antibodies from Murine Variable Regions
- (2010) Matthew J. Bernett et al. JOURNAL OF MOLECULAR BIOLOGY
- Meta-analysis of the Efficacy and Safety of Adalimumab, Etanercept, and Infliximab for the Treatment of Rheumatoid Arthritis
- (2010) Astrid Wiens et al. PHARMACOTHERAPY
- Solution of the Structure of the TNF-TNFR2 Complex
- (2010) Y. Mukai et al. Science Signaling
- Safety and Efficacy of the Tumor Necrosis Factor Antagonists
- (2010) F. Bachmann et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry
- (2009) Merete Lund Hetland et al. ARTHRITIS AND RHEUMATISM
- Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
- (2009) Zehra Kaymakcalan et al. CLINICAL IMMUNOLOGY
- The TNF superfamily in 2009: new pathways, new indications, and new drugs
- (2009) Malú G. Tansey et al. DRUG DISCOVERY TODAY
- Crystal structure of TNFα complexed with a poxvirus MHC-related TNF binding protein
- (2009) Zhiru Yang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety
- (2008) Alberto Alonso-Ruiz et al. BMC MUSCULOSKELETAL DISORDERS
- Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
- (2008) F Schnitzler et al. GUT
- Structure–Function Relationship of Tumor Necrosis Factor (TNF) and Its Receptor Interaction Based on 3D Structural Analysis of a Fully Active TNFR1-Selective TNF Mutant
- (2008) Yohei Mukai et al. JOURNAL OF MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now